161 related articles for article (PubMed ID: 6986413)
21. Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.
Broder S; Poplack D; Whang-Peng J; Durm M; Goldman C; Muul L; Waldmann TA
N Engl J Med; 1978 Jan; 298(2):66-72. PubMed ID: 304175
[TBL] [Abstract][Full Text] [Related]
22. Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin.
Stevenson FK; Elliott EV; Stevenson GT
Immunology; 1977 Apr; 32(4):549-57. PubMed ID: 415966
[TBL] [Abstract][Full Text] [Related]
23. Chronic lymphocytic leukaemia with subsequent development of multiple myeloma. Evidence of two B-lymphocyte clones and of myeloma-induced suppression of secretion of an M-component and of normal immunoglobulins.
Pedersen-Bjergaard J; Petersen HD; Thomsen M; Wiik A; Wolff-Jensen J
Scand J Haematol; 1978 Sep; 21(3):256-64. PubMed ID: 309624
[TBL] [Abstract][Full Text] [Related]
24. Specific suppression of delayed hypersensitivity response to sheep erythrocytes by heterologous anti-lymphocyte serum.
Reuben C; Phondke GP
Immunology; 1979 Nov; 38(3):547-51. PubMed ID: 391699
[TBL] [Abstract][Full Text] [Related]
25. Enhancement and suppression in production of IgM-antibody in mice treated with purified saponins.
Mita A; Shida R; Kasai N; Shoji J
Biomedicine; 1979 Dec; 31(8):223-7. PubMed ID: 394767
[TBL] [Abstract][Full Text] [Related]
26. Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes.
Hough DW; Eady RP; Hamblin TJ; Stevenson FK; Stevenson GT
J Exp Med; 1976 Oct; 144(4):960-9. PubMed ID: 62018
[TBL] [Abstract][Full Text] [Related]
27. Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin.
Maino VC; Kurnick JT; Kubo RT; Grey HM
J Immunol; 1977 Mar; 118(3):742-8. PubMed ID: 403235
[TBL] [Abstract][Full Text] [Related]
28. Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells.
Ferrarini M; Moretta L; Abrile R; Durante ML
Eur J Immunol; 1975 Jan; 5(1):70-2. PubMed ID: 1086217
[TBL] [Abstract][Full Text] [Related]
29. Mediation of cytotoxic functions by classes and subclasses of sheep antibody reactive with cell surface immunoglobulin idiotypic and constant region determinants.
Stevenson FK; Elliott EV
Immunology; 1978 Feb; 34(2):353-8. PubMed ID: 75184
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the immune response by membrane-bound antibody.
Setcavage TM; Kim YB
J Immunol; 1978 Nov; 121(5):1706-10. PubMed ID: 361889
[TBL] [Abstract][Full Text] [Related]
31. Mutant lines of guinea pig L2C leukemia. III. The reaction of an alloantiserum detecting idiotypic determinants on a clonally derived guinea pig B cell leukemia with IgM and Ia molecules.
Konen TG; Green I; Shevach EM; Kask AM; Schwartz BD
J Immunol; 1976 Nov; 117(5 Pt.2):1966-70. PubMed ID: 62799
[TBL] [Abstract][Full Text] [Related]
32. Proteolysis of lymphocytic surface immunoglobulin.
Hough DW; McIlroy BM; Stevenson GT
Immunology; 1977 Mar; 32(3):337-43. PubMed ID: 321347
[TBL] [Abstract][Full Text] [Related]
33. Frequencies of mitogen-reactive B cells in the mouse. II. Frequencies of B cells producing antibodies which lyse sheep or horse erythrocytes, and trinitrophenylated or nitroiodophenylated sheep erythrocytes.
Andersson J; Coutinho A; Melchers F
J Exp Med; 1977 Jun; 145(6):1520-30. PubMed ID: 325169
[TBL] [Abstract][Full Text] [Related]
34. In vivo suppression of the primary immune response by a species of low density serum lipoprotein.
Curtiss LK; DeHeer DH; Edgington TS
J Immunol; 1977 Feb; 118(2):648-52. PubMed ID: 190318
[TBL] [Abstract][Full Text] [Related]
35. Shared idiotypes of human peripheral blood B and T lymphocytes.
Lea T; Førre OT; Michaelsen TE; Natvig JB
J Immunol; 1979 Jun; 122(6):2413-7. PubMed ID: 376734
[TBL] [Abstract][Full Text] [Related]
36. Immunofluorescent demonstration of lymphocyte surface Markers.
Holborow EJ; Papamichail M; Sheldon PJ
Pathol Biol (Paris); 1975 Jun; 23(6):476-8. PubMed ID: 1105348
[TBL] [Abstract][Full Text] [Related]
37. Structure and biological functions of human IgD. XII. Anti-IgD enhancement of PHA responsiveness in patients with chronic lymphocytic leukaemia.
Kermani-Arab V; Leslie GA; Burger DR
Clin Exp Immunol; 1977 Dec; 30(3):450-6. PubMed ID: 414869
[TBL] [Abstract][Full Text] [Related]
38. Significance of surface immunoglobulin in murine and human myeloma and chronic lymphocytic leukemia.
Heller P
Ann Clin Lab Sci; 1978; 8(3):254-7. PubMed ID: 306797
[TBL] [Abstract][Full Text] [Related]
39. Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia.
Fu SM; Chiorazzi N; Kunkel HG
Immunol Rev; 1979; 48():23-44. PubMed ID: 232686
[No Abstract] [Full Text] [Related]
40. Delineation of IgM-receptor bearing human T and B lymphocytes using a direct plaque forming cell (PFC) assay.
Haegert DG
J Immunol Methods; 1979; 28(1-2):83-95. PubMed ID: 381530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
